Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Adnab-9

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Background and AimSporadic pancreatic ductal adenocarcinoma (PDA) is a highly lethal cancer. No proven screening strategies are… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Adnab-9 binding in colonic tissue and effluent has been associated with an increased risk for colorectal neoplasia. We… Expand
Is this relevant?
2004
2004
To better define high-risk populations for colorectal cancer screening, we used anti-adenoma antibody Adnab-9, comparing colonic… Expand
  • table 1
  • table 2
Is this relevant?
2003
2003
Gastric adenocarcinoma (GC), the second most frequent cancer in the world, is highly prevalent in Asia. A screening test for… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • figure 2
Is this relevant?
2001
2001
BACKGROUND Pancreatic intraductal papillary mucinous neoplasms (IPMN), morphologically resembling colonic adenomas, often have an… Expand
Is this relevant?
2001
2001
SummaryBackground. Pancreatic intraductal papillary mucinous neoplasms (IPMN), morphologically resembling colonic adenomas, often… Expand
Is this relevant?
1999
1999
Unlike colorectal cancer, risk markers for adenocarcinoma of the small intestine (ASI) have not been identified. Because the… Expand
Is this relevant?
1992
1992
Adenomatous colonic polyps constitute a precursor for colorectal cancer. Antibodies to these precancerous lesions might identify… Expand
Is this relevant?
1992
1992
The binding in pre-colonoscopic effluent of Adnab-9, a monoclonal antibody raised against colonic adenomas, was evaluated for… Expand
Is this relevant?
1990
1990
A monoclonal antibody Adnab-9, was raised against antigens derived from benign polyps of the colon. Adnab-9 was tested against… Expand
Is this relevant?